Company profile
UK company 10661414, incorporated on 9 March 2017.
Kidney Transplant | Discard Rates | Medical Device
Accunea is the world's first company to use real-time biosensing technology to reduce kidney transplant discard and failure rates. Making sure every organ counts.
Company number 10661414
Financial period: 1 Apr 2023 to 31 Mar 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
AD01 | Transaction MzQyNzY1ODgxMWFkaXF6a2N4
Published 21 Aug 2026 09:49
AD01 | Transaction MzM3NzQ4OTE4NmFkaXF6a2N4 | Paper/PDF filed
Published 21 Aug 2026 09:49
AD01 | Transaction MzM3NzA1NDkwOGFkaXF6a2N4
Published 21 Aug 2026 09:49
AD01 | Transaction MzM3MTYyMTk2NWFkaXF6a2N4
Published 21 Aug 2026 09:49
AD01 | Transaction MzI4NDg5MDUwM2FkaXF6a2N4
Published 21 Aug 2026 09:49
Company registered at Companies House
1 Nov 2018 to 31 Oct 2019
"Across the world today, one fifth of all hospital patients will suffer a kidney injury, and one quarter of these patients will die from this. In the UK alone kidney injury is responsible for an excess of 40,000 deaths per year, and £1bn of NHS spending. We can change this. We have invented a portable bedside chemical analysis device which continuously mo...
